1,4-dihydroxyanthraquinone has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, Y; Hu, J; Hu, X; Wang, W; Yin, X; Zhu, L | 1 |
1 other study(ies) available for 1,4-dihydroxyanthraquinone and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Design and synthesis of various quinizarin derivatives as potential anticancer agents in acute T lymphoblastic leukemia.
Topics: Anthraquinones; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Humans; Jurkat Cells; Molecular Structure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Structure-Activity Relationship | 2019 |